Novel psychoactive substances of interest for psychiatry [PDF]
World Psychiatry, 2015 Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor agonists, a range of prescribed medications, psychoactive plants/herbs, and a large series of performance and ...
John Martin Corkery +2 more
exaly +8 more sources
Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon [PDF]
Brain Sciences, 2018 Over the last decade, the emergence of a vast range of new/novel/emerging psychoactive substances (NPS) has progressively changed drug market scenarios, which have shifted from the ‘street’ to a ‘virtual’/online environment. [...]
Fabrizio Schifano
doaj +5 more sources
The Novel Psychoactive Substances Epidemic: a Scientometric Perspective [PDF]
Addiction Neuroscience, 2022 The unprecedented proliferation of novel psychoactive substances (NPS) in the illicit drug market has been a public health concern since their emergence in the 2000s. Their consumption can pose a severe health risks as their mechanism of action is poorly
M. Neoh +5 more
semanticscholar +6 more sources
An Expanding World of Novel Psychoactive Substances: Opioids. [PDF]
Front Psychiatry, 2017 The abuse of novel psychoactive substances (NPS) has been increasing dramatically worldwide since late 2000s. By the end of 2015, more than 560 NPS had been reported to the European Monitoring Centre for Drugs and Drug Addiction. Although the most popular compounds are synthetic cannabinoids and psychostimulatory derivatives of cathinone (so-called β ...
Zawilska JB.
europepmc +7 more sources
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures. [PDF]
Int J Drug Policy, 2021 Background: Novel psychoactive substances (NPS) present continuous and growing challenges for the scientific, medical, and interventional communities as emerging substances on recreational drug markets change national and international drug landscapes ...
Barenholtz E +10 more
europepmc +2 more sources
Development and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood. [PDF]
Drug Test Anal, 2022 Introduction The analysis of novel psychoactive substances (NPS) represents a challenge in forensic toxicology, due to the high number of compounds characterized by different structures and physicochemical properties both among different subclasses and ...
Giorgetti A +6 more
europepmc +2 more sources
"Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances. [PDF]
Front Psychiatry, 2021 Novel psychoactive substances (NPS) are popular “club/party” drugs that first attracted attention in the UK in 2009 and remained legal until the 2016 Psychoactive Substances Act criminalized their distribution.
Savulich G +6 more
europepmc +2 more sources
Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine. [PDF]
Neuronal Signal, 2021 Drug misuse is a significant social and public health problem worldwide. Misused substances exert their neurobehavioural effects through changing neural signalling within the brain, many of them leading to substance dependence and addiction in the longer
Sahai MA, Opacka-Juffry J.
europepmc +2 more sources
Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances. [PDF]
Int J Mol Sci, 2021 Novel psychoactive substances (NPS) are synthetic substances belonging to diverse groups, designed to mimic the effects of scheduled drugs, resulting in altered toxicity and potency.
Sogos V +7 more
europepmc +2 more sources
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications. [PDF]
Life (Basel), 2021 Novel psychoactive substances (NPS) represent a severe health risk for drug users. Even though the phenomenon has been growing since the early 2000s, the mechanisms of action of NPS at the receptors and beyond them are still scarcely understood.
Giorgetti A +7 more
europepmc +2 more sources